Clinical Trial Update: Somatostatin in Polycystic Kidney: a Long-term Three Year Follow up Study [Phase 3]

View source ↗

Summary

A completed Phase 3 long-term follow-up study evaluating somatostatin in Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autosomal Dominant Polycystic Kidney Disease

Drugs mentioned

• Somatostatin (somatostatin)

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Phase 3 | Status: COMPLETED